摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Benzyl-methylaminomethylen-diphosphonsaeure | 68401-12-7

中文名称
——
中文别名
——
英文名称
Benzyl-methylaminomethylen-diphosphonsaeure
英文别名
[(benzyl-methyl-amino)-methylene]-1,1-bisphosphonate;N-methylbenzylaminomethane-1,1-diphosphonic acid;{[Benzyl(methyl)amino]methylene}bis(phosphonic acid);[[benzyl(methyl)amino]-phosphonomethyl]phosphonic acid
Benzyl-methylaminomethylen-diphosphonsaeure化学式
CAS
68401-12-7
化学式
C9H15NO6P2
mdl
——
分子量
295.169
InChiKey
FOXDWSGGTHOPOM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3.9
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    118
  • 氢给体数:
    4
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    tetraethyl N-benzyl-N-methyl-1-aminomethylenebisphosphonate盐酸 作用下, 反应 8.0h, 以14.3 g的产率得到Benzyl-methylaminomethylen-diphosphonsaeure
    参考文献:
    名称:
    N-甲基烷基氨基甲烷-1,1-二膦酸的合成及其对铜的络合物形成能力的评价(II)
    摘要:
    摘要在反应中合成了一系列具有共同叔氮原子(CH 3 –NR)的带有直链或支链烷基,环庚基或苯基烷基R取代基的N-甲基烷基氨基甲烷-1,1-二膦酸(3a-g)用原甲酸三乙酯和仲胺合成二乙基膦酸酯,然后水解,然后用甲酸和甲醛对烷基氨基甲烷-1,1-二膦酸进行Eschweiler-Clarke甲基化反应。通过pH电位法,ESI-MS光谱法,UV-Vis和EPR方法研究了3a-g对溶液中铜(II)的络合物形成能力。对3a-g的Cu(II)配合物的稳定常数的评估表明,它们依赖于R取代基施加的空间效应和电子效应的组合。已经证明,在N原子(3a,3d,3e)上具有直链或支链烷基的化合物与Cu(II)形成最稳定的配合物,最不稳定的是3f的配合物,这可以归因于所施加的空间效应通过直接与N原子连接的环庚基环 除了主要的[Cu(HL)2]配合物外,还有众所周知的{O,O}螯合结合模式,具有[O,N}供体的[Cu(HL)L]和[CuL
    DOI:
    10.1016/j.poly.2014.09.031
点击查看最新优质反应信息

文献信息

  • Bisphosphonate Inhibitors of <i>Toxoplasma </i><i>g</i><i>ondi </i>Growth:  In Vitro<i>,</i> QSAR, and In Vivo Investigations
    作者:Yan Ling、Gurmukh Sahota、Sarah Odeh、Julian M. W. Chan、Fausto G. Araujo、Silvia N. J. Moreno、Eric Oldfield
    DOI:10.1021/jm040132t
    日期:2005.5.1
    We have investigated the activity of 60 bisphosphonates against the replication of Toxoplasma gondii in vitro and of three of the most active compounds, in vivo. The two most active compounds found were n-alkyl bisphosphonates containing long (n = 9 or 10) hydrocarbon chains, not the nitrogen-containing species used in bone resorption therapy. The target of all of the most active bisphosphonates appears to be the isoprene biosynthesis pathway enzyme farnesyl pyrophosphate synthase (FPPS), as indicated by the correlations between T. gondii growth inhibition and FPPS (human and Leishmania major) enzyme inhibition and by the fact that a T. gondii. strain engineered to overexpress FPPS required considerably higher levels of bisphosphonates to achieve 50% growth inhibition, while the IC50 for atovaquone (which does not inhibit FPPS) remained the same in the overexpressing strain. The phosphonate inhibitor of the non-mevalonate pathway, fosmidomycin, which inhibits the enzyme 1-deoxy-xylulose-5-phosphate reductoisomerase, had no effect on T. gondii growth. To investigate structure-activity relationships (SARs) in more detail, we used two three-dimensional quantitative SAR methods: comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA), to investigate all 60 bisphosphonates. Both the CoMFA and CoMSIA models indicated a 60-70% contribution from steric interactions and a 30-40% contribution from electrostatic interactions and using four N = 55 training sets for each method, we found on average between a factor of 2 and 3 error in IC50 prediction. The three most active compounds found in vitro were tested in vivo in a Smith-Webster mouse model and the two most active bisphosphonates were found to provide up to an 80% protection from death, a considerable improvement over that found previously with nitrogen-containing bisphosphonates. This effect may originate in the much higher therapeutic indices of these alkyl bisphosphonates, as deduced from in vitro assays using LD50 values for growth inhibition of a human cell line. Overall, these results indicate that alkyl bisphosphonates are promising compounds for further development as agents against Toxoplasma gondii growth, in vivo.
  • Maier, Ludwig, Phosphorus and Sulfur and the Related Elements, 1981, vol. 11, p. 311 - 322
    作者:Maier, Ludwig
    DOI:——
    日期:——
  • MAIER, L., PHOSPH. AND SULFUR, 1981, 11, N 3, 311-322
    作者:MAIER, L.
    DOI:——
    日期:——
  • Synthesis of N-methyl alkylaminomethane-1,1-diphosphonic acids and evaluation of their complex-formation abilities towards copper(II)
    作者:Barbara Kurzak、Waldemar Goldeman、Magdalena Szpak、Ewa Matczak-Jon、Anna Kamecka
    DOI:10.1016/j.poly.2014.09.031
    日期:2015.1
    can be attributed to the steric effect imposed by cycloheptyl ring attached directly to the N atom. In addition to the main [Cu(HL) 2 ] complexes, with well-known O, O} chelating binding mode, [Cu(HL)L] and [CuL 2 ] species with the O, N} donor set, protonated dinuclear [Cu 2 H x L 3 ] ( x = 4, 5, 6) species have been detected in all studied systems. The nitrogen coordination in the [Cu(HL)L] and
    摘要在反应中合成了一系列具有共同叔氮原子(CH 3 –NR)的带有直链或支链烷基,环庚基或苯基烷基R取代基的N-甲基烷基氨基甲烷-1,1-二膦酸(3a-g)用原甲酸三乙酯和仲胺合成二乙基膦酸酯,然后水解,然后用甲酸和甲醛对烷基氨基甲烷-1,1-二膦酸进行Eschweiler-Clarke甲基化反应。通过pH电位法,ESI-MS光谱法,UV-Vis和EPR方法研究了3a-g对溶液中铜(II)的络合物形成能力。对3a-g的Cu(II)配合物的稳定常数的评估表明,它们依赖于R取代基施加的空间效应和电子效应的组合。已经证明,在N原子(3a,3d,3e)上具有直链或支链烷基的化合物与Cu(II)形成最稳定的配合物,最不稳定的是3f的配合物,这可以归因于所施加的空间效应通过直接与N原子连接的环庚基环 除了主要的[Cu(HL)2]配合物外,还有众所周知的O,O}螯合结合模式,具有[O,N}供体的[Cu(HL)L]和[CuL
查看更多

同类化合物

(1-氨基丁基)磷酸 顺丙烯基磷酸 除草剂BUMINAFOS 阿仑膦酸 阻燃剂 FRC-1 铵甲基膦酸盐 钠甲基乙酰基膦酸酯 钆1,5,9-三氮杂环十二烷-N,N',N''-三(亚甲基膦酸) 钆-1,4,7-三氮杂环壬烷-N,N',N''-三(亚甲基膦酸) 重氮甲基膦酸二乙酯 辛基膦酸二丁酯 辛基膦酸 辛基-膦酸二钾盐 辛-1-烯-2-基膦酸 试剂12-Azidododecylphosphonicacid 英卡膦酸 苯胺,4-乙烯基-2-(1-甲基乙基)- 苯甲基膦酸二甲酯 苯基膦酸二甲酯 苯基膦酸二仲丁酯 苯基膦酸二乙酯 苯基膦酸二乙酯 苯基磷酸二辛酯 苯基二异辛基亚磷酸酯 苯基(1H-1,2,4-三唑-1-基)甲基膦酸二乙酯 苯丁酸,b-氨基-g-苯基- 苄基膦酸苄基乙酯 苄基亚甲基二膦酸 膦酸,[(2-乙基己基)亚氨基二(亚甲基)]二,triammonium盐(9CI) 膦酸叔丁酯乙酯 膦酸单十八烷基酯钾盐 膦酸二辛酯 膦酸二(二十一烷基)酯 膦酸,辛基-,单乙基酯 膦酸,甲基-,单(2-乙基己基)酯 膦酸,甲基-,二(苯基甲基)酯 膦酸,甲基-,2-甲氧基乙基1-甲基乙基酯 膦酸,丁基乙基酯 膦酸,[苯基[(苯基甲基)氨基]甲基]-,二甲基酯 膦酸,[[羟基(苯基甲基)氨基]苯基甲基]-,二(苯基甲基)酯 膦酸,[2-(环丙基氨基)-2-羰基乙基]-,二乙基酯 膦酸,[2-(二甲基亚肼基)丙基]-,二乙基酯,(E)- 膦酸,[1-甲基-2-(苯亚氨基)乙烯基]-,二乙基酯 膦酸,[1-(乙酰基氨基)-1-甲基乙基]-(9CI) 膦酸,[(环己基氨基)苯基甲基]-,二乙基酯 膦酸,[(二乙氧基硫膦基)(二甲氨基)甲基]- 膦酸,[(2S)-2-氨基-2-苯基乙基]-,二乙基酯 膦酸,[(1Z)-2-氨基-2-(2-噻嗯基)乙烯基]-,二乙基酯 膦酸,P-[(二乙胺基)羰基]-,二乙基酯 膦酸,(氨基二环丙基甲基)-